STAT

Officials fear Ebola epidemic may be spinning beyond their control, threatening regional spread

Public health officials are expressing concern that the latest Ebola outbreak may be spinning beyond their control and could soon spill to neighbors of the DRC.
Nurses working with the WHO prepare to administer Ebola vaccines in Mbandaka, in the Democratic Republic of Congo.

Public health officials are expressing deepening concern that the latest Ebola outbreak in the Democratic Republic of the Congo may be spinning beyond their control and could soon spill over into neighboring countries including Uganda and Rwanda.

With Ebola response teams facing restrictions on their movements in a conflict zone, officials fear containment efforts are falling further behind the virus. And if response teams lose sight of where the virus goes, it could spread undetected and unchecked in places where they cannot safely travel.

“At this point in an epidemic, we’d probably be peaking in terms of knowing where the virus is. And now with the insecurity, that’s compromised,” said Dr. Mike Ryan, assistant director-general of the World Health Organization’s emergency preparedness and response program.

To date in this outbreak — DRC’s 10th — there have been 161 cases and 105 deaths.

Read more:

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About BIO’s China Challenge, Zepbound Shortages, And More
BIO's about-face in its relationship with WuXi AppTec illustrates the difficulty the biotech industry faces in dealing with an issue that is moving fast and forcefully.
STAT1 min read
Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

Related Books & Audiobooks